Miller Richard A Md - Net Worth and Insider Trading

Miller Richard A Md Net Worth

The estimated net worth of Miller Richard A Md is at least $4 Million dollars as of 2024-05-22. Miller Richard A Md is the President and CEO of Corvus Pharmaceuticals Inc and owns about 2,067,753 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $4 Million. Details can be seen in Miller Richard A Md's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Miller Richard A Md has not made any transactions after 2024-05-06 and currently still holds the listed stock(s).

Transaction Summary of Miller Richard A Md

To

Miller Richard A Md Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Miller Richard A Md owns 2 companies in total, including Corvus Pharmaceuticals Inc (CRVS) , and Bolt Biotherapeutics Inc (BOLT) .

Click here to see the complete history of Miller Richard A Md’s form 4 insider trades.

Insider Ownership Summary of Miller Richard A Md

Ticker Comapny Transaction Date Type of Owner
CRVS Corvus Pharmaceuticals Inc 2024-05-06 director & President and CEO
BOLT Bolt Biotherapeutics Inc 2022-03-24 director

Miller Richard A Md Latest Holdings Summary

Miller Richard A Md currently owns a total of 1 stock. Miller Richard A Md owns 2,067,753 shares of Corvus Pharmaceuticals Inc (CRVS) as of May 6, 2024, with a value of $4 Million.

Latest Holdings of Miller Richard A Md

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRVS Corvus Pharmaceuticals Inc 2024-05-06 2,067,753 2.15 4,445,669

Holding Weightings of Miller Richard A Md


Miller Richard A Md Form 4 Trading Tracker

According to the SEC Form 4 filings, Miller Richard A Md has made a total of 15 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 15 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 577,634 shares on May 6, 2024, which cost Miller Richard A Md around $999,307.

Insider Trading History of Miller Richard A Md

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Miller Richard A Md Trading Performance

GuruFocus tracks the stock performance after each of Miller Richard A Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Miller Richard A Md is 3.8%. GuruFocus also compares Miller Richard A Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Miller Richard A Md within 3 months outperforms 10 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Miller Richard A Md's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Miller Richard A Md

Average Return

Average return per transaction

Outperforming Transactions

10 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.15
Relative Return to S&P 500(%) 18.55

Miller Richard A Md Ownership Network

Ownership Network List of Miller Richard A Md

No Data

Ownership Network Relation of Miller Richard A Md


Miller Richard A Md Owned Company Details

What does Corvus Pharmaceuticals Inc do?

Who are the key executives at Corvus Pharmaceuticals Inc?

Miller Richard A Md is the director & President and CEO of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include See Remarks William Benton Jones , Chief Financial Officer Leiv Lea , and 10 percent owner Ecor1 Capital, Llc .

Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary

Over the past 18 months, Miller Richard A Md made 2 insider transaction in Corvus Pharmaceuticals Inc (CRVS) with a net purchase of 637,634. Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 40,000 shares made by William Benton Jones , a net purchase of 34,000 shares made by Leiv Lea , and a net purchase of 10,000 shares made by Linda S Grais .

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 597,634 shares, with a net purchase of 597,634 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 721,634 shares were bought by its insiders, resulting in a net purchase of 721,634 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corvus Pharmaceuticals Inc Insider Transactions

No Available Data

Miller Richard A Md Mailing Address

Above is the net worth, insider trading, and ownership report for Miller Richard A Md. You might contact Miller Richard A Md via mailing address: Pharmacyclics Inc, 995 E Arques Ave, Sunnyvale Ca 94085-4521.

Discussions on Miller Richard A Md

No discussions yet.